Integrating Biomedical Knowledge to Model Pathways of Prostate Cancer Progression

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cell Cycle

• Publication date

  2007-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cc.6.10.4247PMID 17495538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The influence of head and neck position on kinematics of the back in riding horses at the walk and trot.

  2010cited by this paper
• Reciprocal Modifications of CLIC4 in Tumor Epithelium and Stroma Mark Malignant Progression of Multiple Human Cancers

  2007cited by this paper
• Integrative molecular concept modeling of prostate cancer progression

  2007cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 28, 2013. For personal use only.

  2007cited by this paper
• Molecular concepts analysis links tumors, pathways, mechanisms, and drugs.

  2007cited by this paper
• TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.

  2006cited by this paper
• Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

  2006cited by this paper
• Whole transcriptome amplification for gene expression profiling and development of molecular archives.

  2006cited by this paper
• Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

  2006cited by this paper
• Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells.

  2005cited by this paper
• From signatures to models: understanding cancer using microarrays

  2005cited by this paper
• Integrative analysis of the cancer transcriptome

  2005cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Hedgehog signalling in prostate regeneration, neoplasia and metastasis.

  2005cited by this paper
• Prediction of cancer outcome with microarrays: a multiple random validation strategy.

  2005cited by this paper
• An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis

  2005cited by this paper
• The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

  2005cited by this paper
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer - A multi-institutional update

  2004cited by this paper
• Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

  2004cited by this paper
• In silico dissection of cell-type-associated patterns of gene expression in prostate cancer.

  2004cited by this paper
• Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.

  2004cited by this paper
• The KEGG resource for deciphering the genome

  2004cited by this paper
• Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

  2004cited by this paper
• Gene Ontology Consortium: The Gene Ontology (GO) database and informatics resource

  2004cited by this paper
• ONCOMINE: a cancer microarray database and integrated data-mining platform.

  2004cited by this paper
• Molecular determinants of resistance to antiandrogen therapy

  2004cited by this paper
• TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

  2004cited by this paper
• Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

  2004cited by this paper
• Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN.

  2004cited by this paper
• TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

  2004cited by this paper
• Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression.

  2004cited by this paper
• Gene expression profiling predicts clinical outcome of prostate cancer.

  2004cited by this paper
• Molecular Features of the Transition from Prostatic Intraepithelial Neoplasia (PIN) to Prostate Cancer

  2004cited by this paper
• The biology and clinical relevance of the PTEN tumor suppressor pathway.

  2004cited by this paper
• Alterations of androgen receptor in prostate cancer.

  2004cited by this paper
• Microarrays go mainstream

  2004cited by this paper
• Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

  2003cited by this paper
• Statistical significance for genomewide studies

  2003cited by this paper
• Gene expression phenotypic models that predict the activity of oncogenic pathways

  2003cited by this paper
• Myc-driven murine prostate cancer shares molecular features with human prostate tumors.

  2003cited by this paper
• Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.

  2003cited by this paper
• A molecular signature of metastasis in primary solid tumors

  2003cited by this paper
• Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression.

  2003cited by this paper
• PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

  2003cited by this paper
• TRANSFAC®: transcriptional regulation, from patterns to profiles

  2003cited by this paper
• Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.

  2003cited by this paper
• Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.

  2003cited by this paper
• Faculty Opinions recommendation of PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

  2003cited by this paper
• Gene expression correlates of clinical prostate cancer behavior.

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis.

  2002cited by this paper
• Defining the region(s) of deletion at 6q16–q22 in human prostate cancer

  2002cited by this paper
• Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.

  2002cited by this paper
• GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways

  2002cited by this paper
• The polycomb group protein EZH2 is involved in progression of prostate cancer

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Gene-expression profiles predict survival of patients with lung adenocarcinoma

  2002cited by this paper
• Gene expression analysis of prostate cancers

  2002cited by this paper
• Delineation of prognostic biomarkers in prostate cancer

  2001cited by this paper
• Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia.

  2001cited by this paper
• Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.

  2001cited by this paper
• Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer

  2001cited by this paper
• Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

  2001cited by this paper
• The development of androgen-independent prostate cancer

  2001cited by this paper
• Expression profiling reveals hepsin overexpression in prostate cancer.

  2001cited by this paper
• High-fidelity mRNA amplification for gene profiling

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Roles for Nkx3.1 in prostate development and cancer.

  1999cited by this paper
• Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.

  1999cited by this paper
• A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

  1998cited by this paper
• Maximum Androgen Blockade Using LHRH Agonist Buserelin in Combination with Short-Term (Two Weeks) or Long-Term (Continuous) Cyproterone Acetate Is Not Superior to Standard Androgen Deprivation in the Treatment of Advanced Prostate Cancer

  1998cited by this paper
• Genetic alterations in hormone-refractory recurrent prostate carcinomas.

  1998cited by this paper
• Interobserver variation in prostate cancer Gleason scoring: are there implications for the design of clinical trials and treatment strategies?

  1997cited by this paper
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

  1997cited by this paper
• Laser Capture Microdissection

  1996cited by this paper
• Identification and characterization of proximal 6q deletions in prostate cancer.

  1996cited by this paper
• Accessing Genetic Information with High-Density DNA Arrays

  1996cited by this paper
• The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.

  1995cited by this paper
• Long-term survival among men with conservatively treated localized prostate cancer.

  1995cited by this paper
• Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray

  1995cited by this paper
• Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.

  1994cited by this paper
• Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

  1974cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• GENE EXPRESSION PROFILING AND CLINICAL RELEVANCE TO UNDERSTAND THE ROLE OF HYPOXIA AND IMMUNE SIGNALING GENES AND PATHWAYS IN BREAST CANCER

  2020cites this paper
• NADPH Oxidases: A Perspective on Reactive Oxygen Species Production in Tumor Biology

  2014cites this paper
• The role of galanin in perineural invasion of head and neck cancer

  2014cites this paper
• Profiling prostate cancer

  2011cites this paper
• RNA quality in fresh frozen prostate tissue from patients operated with radical prostatectomy

  2010cites this paper
• Applications of molecular imaging.

  2010cites this paper
• Construction of Cancer-Perturbed Protein–Protein Interaction Network of Apoptosis for Drug Target Discovery

  2010cites this paper
• ConceptGen: a gene set enrichment and gene set relation mapping tool

  2010cites this paper
• Identification of metastasis-associated genes in prostate cancer

  2010cites this paper
• Preclinical Cell and Tumor Models for Evaluating Radiopharmaceuticals in Oncology

  2010cites this paper
• Cholesterol Homeostasis in Two Commonly Used Human Prostate Cancer Cell-Lines, LNCaP and PC-3

  2009cites this paper
• Pro-apoptotic effect of aurothiomalate in prostate cancer cells

  2009cites this paper
• Pharmacogenomic and mechanistic studies on dietary factors in chemoprevention of cancer

  2008cites this paper
• Modeling Networks of Glycolysis, Overall Energy Metabolism and Drug Metabolism under a Systems Biology Approach

  2008cites this paper
• ANALYSIS OF FUNCTIONAL GENETIC POLYMORPHISMS IN PROSTATE CANCER AND TYPE 2 DIABETES: GROWTH HORMONE RECEPTOR AND MUCIN 1

  2008cites this paper
• Targeting prostate cancer based on signal transduction and cell cycle pathways

  2008cites this paper